Skip to main content Help with accessibility Skip to main navigation

FINERENONE tablets (Kerendia®▼) for treating chronic kidney disease (CKD) in type 2 diabetes

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 25 - May - 2023
Body System:
Amber initiated
FINERENONE tablets (Kerendia®▼) for treating chronic kidney disease (CKD) in type 2 diabetes

The Cheshire and Merseyside Area Prescribing Group recommends the prescribing of FINERENONE tablets (Kerendia®▼), for treating chronic kidney disease (CKD) in type 2 diabetes in accordance with NICE TA877.

NHS Cheshire and Merseyside APPROVED